The 58 rating InvestorsObserver gives to Intellia Therapeutics Inc (NTLA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 92 percent of stocks in the Biotechnology industry, NTLA’s 58 overall rating means the stock scores better than 58 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Intellia Therapeutics Inc Stock Today?
Intellia Therapeutics Inc (NTLA) stock is trading at $80.21 as of 1:28 PM on Wednesday, Jun 16, a drop of -$8.44, or -9.52% from the previous closing price of $88.65. The stock has traded between $80.10 and $89.00 so far today. Volume today is 1,027,092 compared to average volume of 1,201,929.
Click Here to get the full Stock Score Report on Intellia Therapeutics Inc (NTLA) Stock.
